A patient initially diagnosed with adductor-type spasmodic dysphonia was referred for botulinum toxin (Botox) injections, but found on subsequent evaluation to have amyotrophic lateral sclerosis, and therefore Botox was not administered. This unique case underscores the need to delay botulinum toxin treatments in any patient with recent onset symptoms, and to obtain thorough motor speech and voice, otolaryngologic, and neurologic evaluation in all patients prior to consideration for injection.
|Original language||English (US)|
|Number of pages||6|
|Journal||Journal of Voice|
|State||Published - 1996|
- Amyotrophic lateral sclerosis
- Botulinum toxin
- Spasmodic dysphonia